Cells derived from human cord blood were recently used instead of bone marrow (BM) for transplantation. However, several questions concerning the potential of these cells t o reconstitute the hematopoietic and immunologic system of the recipient and t o induce a graft-versus-host disease (GVHD) remain unanswered. Here we used newborn blood (NBB) cells from 610.D2 mice t o engraft lethally irradiated (DBAI2 x B1O.DP)Fl recipients incompatible for multiple non H-2 antigens. Few mature T cells were found in NBB as in adult BM and both contain around 10% t o 20% SCA-l+ pluripotent progenitor cells. Yet numerous immature CD4+CD8+ TCR~Y//~'~" Thy-lhigh T cells were present in NBB. In contrast, adult peripheral blood (PB) exhibits a mature T-cell phenotype and contains few progenitor cells. The injection of blood pooled from one t o three newborn mice resulted in the engraftment of 71% t o 86Yo of F1 recipients, which survived more than 100 days without clinical signs of GVHD.
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ONE MARROW (BM) transplantation is widely used B for treatment of malignant and nonmalignant disorders but is often complicated by the occurrence of a graft-versushost disease (GVHD).' The elimination of mature T cells from the BM graft reduces the GVHD but increases graft failure and malignant relapse? An additional difficulty arises from the frequent lack of suitable marrow from familial HLA-matched donors, which therefore leads to transplantation between HLA-matched unrelated donors and recipients and thus increases the risk of GVHD. For these reasons the search for new sources of cells for transplantation is necessitated.
Recently, considerable interest has arisen in the use of human umbilical cord blood (CB) for therapeutic reconstitution. This was proposed in part following to the experimental observations of E. Boyse and colleagues, reported in Broxmeyer et al," who obtained a successful reconstitution of lethally irradiated mice with syngeneic neonatal blood. Furthermore, in vitro studies have shown that CB contains large numbers of hematopoietic progenitors with a high proliferative potential relative to adult peripheral blood (PB).3-5 Another theorical advantage of the use of CB is a reduced risk of GVHD because of the relative immaturity of T ~ells. 6 .~ Preliminary results of CB transplantation in pediatric patients"." are encouraging but many questions remained unanswered; particularly, those addressing the capacity for a single CB to reconstitute adult patients, the GVHD incidence in relation to the degree of mismatching, and the preservation of a beneficial graft-versus-leukemia (GVL) effect.
The purpose of this work was to develop an experimental in vivo model, which could bring useful informations for clinical CB transplantation. To this effect, newborn blood (NBB) cells derived from B 10.D2 donor were transplanted in lethally irradiated H-2 compatibie (DBA/2 X BlO.D2)FI recipients. In this genetic combination, donor and recipient differ for multiple DBN2 minor histocompatibility Ags (mHAgs) and also for Mls-1" and Mls-2" superantigens encoded by endogenous mouse mammary tumor virus Mtv-7 and Mtv-6, respectively. A lethal GVHD developed in nearly 100% of (DBN2 X BlO.D2)Fl recipients engrafted with
The injection of BM leads t o 100% survival whereas the injection of adult PB resulted in rapid mortality, both without signs of GVHD. In NBB-engrafted F1 surviving mice, T-cell reconstitution preceded B-cell reconstitution, and the degree of donor cell chimerism increased progressively with time. Additionally, 2 t o 4 months after transplantation, T cells from these mice were tolerant t o host non H-2 antigens but kept reactivity against third-party Ags. Host specific tolerance in NBB-engrafted F l mice was confirmed by in vivo transfer experiments. In conclusion, NBB cells were able t o reconstitute the lymphohematopoietic system of lethally irradiated adult mice without inducing GVHD against incompatible non H-2 antigens. Thus, this experimental model in vivo may be relevant t o the human cord blood transplantation. BM and lymphoid cells from adult B 10.D2 mice.'" Our current study focused on T-cell phenotype and content in PB collected at birth and evaluated the number of cells required to achieve permanent engraftment. Additionally, we investigated the degree of chimerism and the incidence of GVHD across host non H-2 Ags.
Using this approach, we showed that the blood of one newborn mouse contained a sufficient number of progenitors to reconstitute 70% of F1 recipients, which afterward survived without clinical signs of GVHD, become mixed chimera and developed a host-specific tolerance.
MATERIALS AND METHODS

B10.D2 (H-2d, M I s -I~~~) ,
DBA12 (H-2d, Mls-1"2"), ( D B N 2 x BlO.D2)FI (H-2ud, Mls-1*2dh), C57BW6 (H-2b, M I s -I~~~) , and (BALBk X C57BW6)FI (H-2dm, Mls-lhh2*) were bred in our own facilities.
The PB from individual adult or newborn B 10.D2 mice was collected on Calciparin. The volume of blood obtained from one newborn mouse ranged from 40 to 50 pL. The PB from 6 to 8 individual newborn mice from the same litter were pooled and mononuclear cells were prepared using FicoWHypaque gradients (1090, Pharmacia, Uppsala, Sweden). The PB from one adult mouse (500 to 800 pL) was similarly separated on FicolVHypaque gradient (1077, Pharmacia). Mononuclear cells from adult or newborn PB and from adult BM were labeled with monoclonal antibodies (MoAbs): fluorescein isthiocyanate (FITC) or PE-conjugated anti-CM, anti-CD8, anti-TCRalP (Pharmingen, Clinisciences, France) and anti-Thy-1 (Coulter, Nargency, France); unconjugated rat MoAb against stem cell antigen (SCA-I, clone Fall-3". Pharmingen) and mouse MoAb against Lyt-1.1 allele (Coulter) were revealed by FITC-conjugated goat antirat Ig (GAR, Coulter) or by FITC-conjugated goat antimouse Ig (GAM, Coulter), respectively. Briefly, 5 X 10' cells were incubated 30 minutes at 4°C with the corresponding MoAb. After washing, the cells were stained with the specific second reagent. In some cases, PE-conjugated anti-CD4 and anti-CD8 were added during the second incubation period. Samples of 10.000 cells were analyzed on a flow cytometer (Profile 11, Coulter) and the percentage of single or double positive cells was calculated.
Mice
Mixed lymphocyte reaction (MLR) and mitogen stimulation. Cells (2 X 10' per well) from adult or newbom PB and from adult BM and lymph nodes were cultured with phytohemagglutinin (PHA) or concavalin A (Con A) mitogens and with irradiated splenocytes (4 X IO' per well) from different strains of mice. Spleen cells (4 x 10' per well) from B10.D2 mice immunized 14 days previously with 5 X 10' DBA/2 cells (Si mice) or from NBB-engrafted F1 mice collected 2 to 3 months after transplantation were cultured in the presence of irradiated splenocytes (4 x 10' per well) from different mouse strains. Proliferation was evaluated 2 days (cultures with mitogens) or 3 days (cultures with irradiated spleen cells) later by 3H-thymidine incorporation, added during the last 18 hours of cultures.
After a 5 day-MLR in the presence of irradiated DBN2 (host-specific) or C57BL/6 (H-2 unrelated) cells, spleen cells from B10.D2 Si or NBB-engrafted F1 mice were incubated with "Cr labeled P8 15 (DBA/2 specific) or "Cr-EL4 (C57BL/ 6, H-2 unrelated) target cells, at different effector to target ratios (ET). Four hours later, the amount of "Cr released was measured in the supernatants and used to calculate the percentage of cytotoxicity.
IO7 BM cells and 8 X 10' spleen cells collected from NBB-engrafted F1 mice, were injected either into lethally irradiated (BALB/c X C57BL/6)F1 recipients incompatible for H-2h and BALB/c mHAgs or into (DBAR X BlO.D2)FI recipients incompatible for DBA/2 host Ags. The ensuing rate and incidence of lethal GVHD was measured.
Phenotype characterization.
Cytotoxic assay (CTL).
In vivo transfer experiments. (Fig 2) . The addition of =2 to 3 X 1 0' mature T cells derived from 8 X lo6 adult B 10.D2 spleen induced the development of a lethal GVHD across DBN2 non H-2 Ags with a median survival time (MST) of 40 days. Recipients receiving 6 X IO5 adult PB cells died rapidly (MST = 10 days) without signs of GVHD. In contrast the injection of the blood of one newbom mouse (equivalent to 5 X 10' cells) or the blood pooled from two (10' cells) or three (1.5 X 10' cells) B10.D2 newborn mice yielded successful engraftment of FI mice with a percent survival of 71% to 86%. In addition, these mice survived more than 100 days without clinical signs of GVHD.
RESULTS
Phenotype characterization
Evaluation of the degree of chimerism in MBB-engrafted F l mice. To ensure that reconstitution was achieved by cells of donor origin and not by residual cells of host origin, the Lyt-1.1 phenotype (specific of DBN2 cells) of lymph nodes T cells was examined in FI recipients. As the mouse anti-Lyt-I. 1 MoAb is not labeled, we used FITC-conjugated goat antimouse Ig MoAb (GAM) as a second reagent. This reagent stained mainly B cells which represents 30% to 50% of the LN cells (Fig 3 , top) . Results shown in the bottom panel of Fig 3 confirmed that Lyt-1.1 marker is expressed only on T cells of recipient DBN2 haplotype and not on donor B10.D2 haplotype. Two months after the graft of F1 mice with two NBB, 30.9% Lyt-1.1' were detected within the CD4' and CD8' T cells. This indicated that a mixed chimerism with approximatively 69% of T cells originating from donor NBB was achieved in long-term surviving F1 mice. Further, we studied the kinetics and the degree of Tcell chimerism established in NBB-engrafted F1 mice relative to the number of NBB injected. We showed that the rate of establishment of chimerism depends on the initial dose of NBB injected; Table 3 shows that 71.7% of donor cell repopulation was achieved in the LN of F1 recipients as early as 13 to 15 days after the graft of three NBB pooled samples while, at the same time. the injection of one NBB sample resulted in only 40.2% chimerism. Additionally, this study showed that the level of chimerism significantly increased with time after the graft of one or two NBB and that the maximum (82%) was reached only 6 months after the graft. mice. Fluorescence analysis of the percentases of CD4-and CD8' T-cell subsets and of B cells (If+ cells stained with GAM MoAb) in the lymph nodes of NBB-engrafted FI mice at different times after transplantation. presented in Table 4 , indicated that T-cell recovery occured earlier (between 13 to 19 days after grafting) than B-cell recovery (at 2 months). Additionally. whereas CD8' T cells retumed progressively to normal levels. CD4' T cells infiltrated lymph nodes soon after engraftment then decreased with time.
Estcihlishmerrt of N host specific tolernnce iri NBB-engrqfled F I mice. Two to three months after the graft. the proliferative and cytotoxic capacity of spleen cells from NBB-engrafted FI mice was evaluated in response to D B N 2 host non H-2 Ags and to H-2 third-party Ags and compared with that of B10.D2 mice immunized with DBA/2 Ags (Si mice). Table 5 indicates that BIO.D2 Si mice proliferate optimally in response to host non H-2 Ags (mHAgs + Mls-I") expressed on DBA/2 and to H-2h expressed on C57BL/ 6. In contrast. cells from two individual NBB-engrafted FI mice were totally unresponsive to mHAgs and MIS-I" expressed on DBA/2. but were still reactive to H-2h expressed on C57BL16 cells.
Similarly, a significant CTL reactivity of splenocytes from two individual NBB-engrafted FI mice was detected against H-2h third-party Ags expressed on EL4 targets (458 at an effector to target ratio of 10O:l) (Fig 4) . It has to be noted that both the level of the proliferative and cytotoxic reFor personal use only. on April 18, 2017. by guest www.bloodjournal.org From sponses against H-2h of the two NBB-engrafted F1 mice newborn mice as a source of transplantable cells. This analywere lower than that of the Si mice.
This may be because sis confirmed the previous observations that NBB cells can of the nonspecific immunosuppression remaining for a long reconstitute syngeneic adult mice and further showed that period of time after irradiation and reconstitution in enthey are also able to engraft recipients incompatible for non grafted mice even in the absence of GVHD. The cytotoxicity H-2 Ags without inducing a GVHD. against DBA/2 mHAgs expressed on P815 targets was very As already known, BM cells perfectly engrafted recipients strong when the effectors were derived from Si mice because whereas PB fails to do so because of an insufficient number they were previously primed against DBA/2 mHAgs (95% of progenitor cells. Moreover, in vivo graft experiments indiat E:T = 1OO:l). A minimal CTL reactivity (20% at E:T = cate that more than 70% of lethally irradiated F1 recipients 1OO:l) was generated when splenocytes were derived from inoculated with one to three NBB sample survived. Fluoresthe two NBB-engrafted FI mice. cence analysis determined that NBB contained approximaIn addition, spleen cells from long-term surviving NBB-tively 17% and BM 12.5% of SCA-I' cells. The MoAb Fallengrafted F1 mice, when grafted together with BM cells, 3 used was shown to recognize a SCA-I Ag different from retained their ability to induce lethal GVHD in irradiated that detected by MoAb Ly 6A/E, and to be expressed on (BALB/c X C57BL/6)F1 recipients incompatible for H-2h most of pluripotent progenitor cells but not on mature granuthird-party Ags (Fig 5) . In contrast, the same cells injected locytes, macrophages, T or B lymphocytes.'' Stem cells repinto irradiated (DBA/2 X BIO.D2)Fl recipients incompatible resented only a minor subset of the SCA-I' cells. Although for DBA/2 mHAgs and MIS superantigens were unable to in this study we did not compare the hematopoietic reconstiinitiate a lethal GVHD over a 3 month period of observation.
tutive capacity of NBB and BM cells, the in vivo data indiAltogether, the data showed that NBB-engrafted FI recipicated that only a small number of progenitors from NBB are ents developed a host-specific tolerance which preserved at least partially immunoreactivity for H-2 unrelated Ags. For t Pvalue (student test) between each point with the last one b120).
required to repopulate permanently the host hematopoietic system. These results are in line with human data suggesting that CB contains hematopoietic stem cells with long-term repopulating capacity." A recent study reports that a stable human long-term hematopoiesis was observed in CB transplanted severe combined immunodeficiency (SCID) mice for at least 3 months, indicating the engraftment of early hematopoietic progenitor cell^.^ In another approach, Davenport et all2 have transplanted newbom liver cells to investigate the role of T cells in engraftment. However the survival and GVHD incidence was not explored after transplantation of this source of cells. Donor engraftment, evaluated by the proportion of Lyt-1.1 T cells of recipient origin, settled slowly in NBB-engrafted F1 mice and a mixed chimerism was observed over a long period of time before reaching a maximum of 80% of donor cells. To explain the mixed chimerism, we hypothesized that the few residual progenitors of recipient BM compete for early restoration with progenitors of donor NBB which expanded progressively. Consistently, it has been reported that human BM contains a higher number of later progenitors, which are important for short-term reconstitution, and conversely that CB possesses more CD34+CD38-primitive stem cells that are important for long-term hematopoiesis.I3 This hypothesis is further supported by in vitro data showing that CB stem cells have a higher proliferative than BM stem cells and that they can be maintained in liquid cultures for many weeks.14r15
Fluorescence analysis of NBB subpopulations evidenced that the majority of T cells possessed the characteristics of immature T cells and expressed a double positive CD4'CD8+ phenotype with a low level of TCRaIB. It should be noted that the percentage of CD4+CD8', Thy-1' cells and SCA-1' cells varied considerably between individual samples. These differences can be because of the purification procedure. Alternatively, as the content of CD4'CD8+ T cells and SCA-1+ populations decrease rapidly with the maturation process (data not shown), these variations can result from the time between birth and blood collection which ranged from 1 to 15 hours. Such an immature T-cell population was identified in the lymph nodes of 3 day-old mice and had dropped significantly by day eight.I6 The double positive T cells present in the peripheral lymph nodes were found to express a phenotype very similar to that of double positive thymocytes and to be exported from the thymus to the periphery where they could complete their maturation For personal use only. on April 18, 2017 . by guest www.bloodjournal.org From process." It is not known at the moment whether immature T cells of NBB and of 3-day-old lymph nodes are of the same origin. Induction of lethal GVHD in this murine model was previously shown to require the injection of a minimum of 10' total spleen cells together with lo7 BM cells.17 Else the graft of 1.5 X 10' NBB cells or lo7 BM cells alone to lethally irradiated F1 recipients was not able to induce either mortality or clinical signs of GVHD across non H-2 barriers. The failure of BM cells to initiate a GVHD is because of an insufficient number of mature CD4+CD8-or CD4-CD8+ T cells (less than 5% of mononucleated cells) that achieved both a minimal proliferative response to phytohemagglutinin and to alloantigen. In the case of NBB, both the low percentage of mature T cells (3% to 5%) and the weak reactivity of the numerous immature T cells (40%) are responsible for the lack of GVHD. Harris et a17 reported that human CB contains a more immature population of lymphocytes than adult PB with a reduced number of CD3', CD4+, and CD8+ T cells and a lower CD3 molecule expression. However, conflicting results have been reported with regard to the functional reactivity of these ~e l l s '~~~~~" and particularly with regard to the frequency of alloreactive Th and CTL precursors.I9 Despite the features of immaturity exhibited by human CB T cells, they appear to be in a more mature state than murine NBB T cells and therefore more able to initiate a GVHD. Thus these data indicate that the number of T cells (mature or immature) present in NBB is sufficient to avoid rejection and to achieve permanent engraftment without inducing GVHD across non H-2 barrier but do not ensure that consequently the risk of malignant relapse is not increased.
In preliminary experiments, we observed that the blood collected from 2 to 5 day-old mice contains increasing numbers of mature CD4+CD8-and CD4-CD8' lymphocytes and still has a significant amount of SCA-l+ progenitor cells (manuscript in preparation). An experimental model using cells from these older mice may be more relevant to the human CB transplantation and particularly in relation to the GVHD and GVL potential. The NBB-engrafted F1 mice became specifically tolerant to host non H-2 Ags. A deletional mechanism may account for this process: for instance, Vp6' T-cell specific for Mls-1" were completely absent from those mice (data not shown). Yet, T-cell tolerance may not be due exclusively to deletion but also to peripheral inactivation. Moreover, the CD4+CD8+ T-cell population from the donor NBB may preferentially differentiate into cells of TH2 phenotype, which have been correlated with the state of tolerance.'".'' Indeed, a high level of interleukin-4 but not of interleukin-:! was detected in splenic and lymph nodes T cells of 3-day-old mice .* ' .*'
In conclusion, these results do argue for the possible use of NBB as a source of cells for transplantation. Indeed, NBB yields enough progenitor cells to achieve a full engraftment in adult mice and thus supports the assumption of several investigators','*," that a single CB collection might be suffi- For personal use only. on April 18, 2017 . by guest www.bloodjournal.org From cient to reconstitute adult patients. Despite the phenotypic and functional differences between murine NBB cells and human CB cells, this experimental approach may be suitable for addressing questions concerning the degree of major histocompatibility complex incompatibilities acceptable in regard to the risk of GVHD, the existence of a suppressor activity and the preservation of a GVL effect.
